SeaStar Medical Holding (ICU)
SeaStar Medical Holding on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
186K
Short interest
settlement 2026-10-15
1.0
Days to cover
-2.2 days vs prior
57.0%
Short share of volume
2026-11-03
44,694
Fails to deliver
settlement 2026-10-09
Thu 12 Nov
Next earnings
estimated date
$2K
Insider flow, 90 days
1 buys, 0 sells
As of 2026-11-03.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ICU is 185,839 shares, up 64,153 shares over the last month. Over the last 48 readings it ranged from 79,633 shares (13 June 2025) to 5,115,929 shares (30 September 2025). The latest reading sits at the bottom of that range. At the reported average volume of 360K shares a day that is 1.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/icu" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 185,839 | +29.3% | 359,956 | 1.00 |
| 2026-09-30 | 143,724 | +18.1% | 45,487 | 3.16 |
| 2026-09-15 | 121,686 | +10.0% | 44,628 | 2.73 |
| 2026-08-31 | 110,622 | -9.1% | 47,578 | 2.33 |
| 2026-08-14 | 121,687 | +33.5% | 92,026 | 1.32 |
| 2026-07-31 | 91,177 | -34.4% | 60,436 | 1.51 |
| 2026-07-15 | 138,925 | +69.6% | 149,755 | 1.00 |
| 2026-06-30 | 81,907 | -36.7% | 74,907 | 1.09 |
| 2026-06-15 | 129,310 | -8.5% | 102,150 | 1.27 |
| 2026-05-29 | 141,315 | -8.8% | 68,481 | 2.06 |
| 2026-05-15 | 154,907 | -28.9% | 89,114 | 1.74 |
| 2026-04-30 | 217,777 | +36.6% | 90,184 | 2.41 |
| 2026-04-15 | 159,384 | -25.9% | 170,885 | 1.00 |
| 2026-03-31 | 215,212 | +28.1% | 318,775 | 1.00 |
| 2026-03-13 | 167,946 | -28.0% | 57,628 | 2.91 |
| 2026-02-27 | 233,272 | -18.5% | 43,336 | 5.38 |
| 2026-02-13 | 286,335 | +85.5% | 108,978 | 2.63 |
| 2026-01-30 | 154,400 | +13.1% | 110,926 | 1.39 |
| 2026-01-15 | 136,473 | -86.3% | 182,374 | 1.00 |
| 2025-12-31 | 996,651 | -1.4% | 1,258,876 | 1.00 |
| 2025-12-15 | 1,010,331 | -67.1% | 1,603,318 | 1.00 |
| 2025-11-28 | 3,074,030 | +669.1% | 5,307,420 | 1.00 |
| 2025-11-14 | 399,709 | -35.2% | 877,563 | 1.00 |
| 2025-10-31 | 616,671 | -73.5% | 1,016,530 | 1.00 |
| 2025-10-15 | 2,326,990 | -54.5% | 2,366,817 | 1.00 |
| 2025-09-30 | 5,115,929 | +14.4% | 5,103,754 | 1.00 |
| 2025-09-15 | 4,471,307 | +42.9% | 1,072,367 | 4.17 |
| 2025-08-29 | 3,128,638 | +95.9% | 1,073,690 | 2.91 |
| 2025-08-15 | 1,597,304 | -22.9% | 1,906,535 | 1.00 |
| 2025-07-31 | 2,071,239 | +259.7% | 5,480,550 | 1.00 |
| 2025-07-15 | 575,798 | -80.5% | 6,861,850 | 1.00 |
| 2025-06-30 | 2,945,797 | +3599.2% | 31,797,974 | 1.00 |
| 2025-06-13 | 79,633 | -46.0% | 141,957 | 1.00 |
| 2025-05-30 | 147,443 | +29.6% | 150,806 | 1.00 |
| 2025-05-15 | 113,798 | -59.7% | 140,739 | 1.00 |
| 2025-04-30 | 282,268 | -35.4% | 91,365 | 3.09 |
| 2025-04-15 | 437,149 | -18.6% | 228,285 | 1.91 |
| 2025-03-31 | 536,873 | +60.3% | 257,749 | 2.08 |
| 2025-03-14 | 334,920 | -6.3% | 157,510 | 2.13 |
| 2025-02-28 | 357,619 | +18.8% | 150,081 | 2.38 |
| 2025-02-14 | 300,913 | -18.7% | 799,873 | 1.00 |
| 2025-01-31 | 370,190 | -11.2% | 799,355 | 1.00 |
| 2025-01-15 | 416,651 | +11.1% | 232,934 | 1.79 |
| 2024-12-31 | 375,148 | -27.6% | 189,978 | 1.97 |
| 2024-12-13 | 518,241 | +53.3% | 402,093 | 1.29 |
| 2024-11-29 | 338,102 | +0.3% | 201,393 | 1.68 |
| 2024-11-15 | 337,056 | +17.0% | 364,147 | 1.00 |
| 2024-10-31 | 288,068 | +38.0% | 87,565 | 3.29 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 3 November 2026, the short share of ICU volume is 57.0%, up 15.2 points over the last five sessions. Over the last 30 readings it ranged from 19.3% (25 September 2026) to 89.8% (29 September 2026). The latest reading is 4.3 points above the 30-session average of 52.7%, on 509K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-03 | 290K | 509K | 57.0% | 49,005 |
| 2026-11-02 | 12K | 43K | 27.0% | 50 |
| 2026-10-30 | 15K | 40K | 37.9% | 0 |
| 2026-10-29 | 37K | 69K | 53.6% | 100 |
| 2026-10-28 | 6K | 17K | 37.7% | 0 |
| 2026-10-27 | 19K | 46K | 41.8% | 0 |
| 2026-10-26 | 35K | 64K | 54.3% | 8,104 |
| 2026-10-23 | 89K | 211K | 42.0% | 20,838 |
| 2026-10-22 | 60K | 172K | 34.8% | 2,024 |
| 2026-10-21 | 28K | 43K | 65.5% | 0 |
| 2026-10-20 | 44K | 58K | 75.7% | 0 |
| 2026-10-19 | 31K | 69K | 44.8% | 0 |
| 2026-10-16 | 38K | 78K | 48.7% | 500 |
| 2026-10-15 | 103K | 160K | 64.4% | 34,325 |
| 2026-10-14 | 158K | 319K | 49.5% | 31,333 |
| 2026-10-13 | 41K | 76K | 54.0% | 200 |
| 2026-10-12 | 37K | 68K | 53.8% | 0 |
| 2026-10-09 | 19K | 48K | 40.2% | 2,839 |
| 2026-10-08 | 67K | 105K | 64.2% | 6,850 |
| 2026-10-07 | 365K | 637K | 57.3% | 55,738 |
| 2026-10-06 | 91K | 163K | 55.9% | 17,507 |
| 2026-10-05 | 148K | 300K | 49.2% | 15,397 |
| 2026-10-02 | 262K | 362K | 72.2% | 93 |
| 2026-10-01 | 6K | 11K | 54.2% | 0 |
| 2026-09-30 | 28K | 48K | 59.3% | 0 |
| 2026-09-29 | 80K | 89K | 89.8% | 0 |
| 2026-09-28 | 6K | 7K | 76.0% | 0 |
| 2026-09-25 | 4K | 18K | 19.3% | 0 |
| 2026-09-24 | 2K | 9K | 24.6% | 0 |
| 2026-09-23 | 6K | 8K | 75.5% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in ICU is 44,694 shares, down 107,276 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (24 August 2026) to 151,970 shares (8 October 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 44,694 | $3.49 | $156K |
| 2026-10-08 | 151,970 | $3.72 | $565K |
| 2026-10-07 | 30,068 | $3.19 | $96K |
| 2026-10-06 | 140,500 | $3.55 | $499K |
| 2026-10-05 | 360 | $4.69 | $2K |
| 2026-10-02 | 1,379 | $3.75 | $5K |
| 2026-10-01 | 247 | $3.94 | $973 |
| 2026-09-18 | 1,786 | $3.48 | $6K |
| 2026-09-08 | 443 | $2.95 | $1K |
| 2026-08-24 | 1 | $3.35 | $3 |
| 2026-08-20 | 1,360 | $3.27 | $4K |
| 2026-08-13 | 1,834 | $3.36 | $6K |
| 2026-07-17 | 2,035 | $4.22 | $9K |
| 2026-07-06 | 248 | $4.92 | $1K |
| 2026-07-02 | 299 | $4.86 | $1K |
| 2026-06-24 | 1,220 | $3.47 | $4K |
| 2026-06-23 | 3,970 | $3.24 | $13K |
| 2026-06-22 | 2,107 | $3.12 | $7K |
| 2026-06-17 | 545 | $3.04 | $2K |
| 2026-06-15 | 1,373 | $2.98 | $4K |
| 2026-06-05 | 31,190 | $3.13 | $98K |
| 2026-06-04 | 34,102 | $3.28 | $112K |
| 2026-06-03 | 44,317 | $3.53 | $156K |
| 2026-06-02 | 1,498 | $3.64 | $5K |
| 2026-06-01 | 1,782 | $3.71 | $7K |
| 2026-05-28 | 3,729 | $3.59 | $13K |
| 2026-05-27 | 2,772 | $3.58 | $10K |
| 2026-05-13 | 820 | $4.84 | $4K |
| 2026-05-08 | 63 | $4.86 | $306 |
| 2026-05-05 | 3 | $4.33 | $13 |
Insider trades
SEC Form 4, newest first. JSONInsiders at ICU reported 1 open-market buy worth $2K in the last 90 days and no open-market sells. Latest filing: Messinger Michael (Chief Financial Officer) on 2026-08-18.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Messinger Michael | Chief Financial Officer | Buy | 750 | $3.27 | $2K | 3K |
| 2026-07-01 | Vincent Bernadette N | Director | Grant | 4K | $0.00 | $0 | 8K |
| 2026-07-01 | Van Heel Kenneth | Director | Grant | 4K | $0.00 | $0 | 12K |
| 2026-07-01 | Schlorff Eric | Chief Executive Officer | Grant | 10K | $0.00 | $0 | 50K |
| 2026-07-01 | Neuman John | Director | Grant | 4K | $0.00 | $0 | 16K |
| 2026-07-01 | Chung Kevin | Chief Medical Officer | Grant | 7K | $0.00 | $0 | 28K |
| 2026-07-01 | Baird Jennifer A | Director | Grant | 4K | $0.00 | $0 | 11K |
| 2026-02-06 | Van Heel Kenneth | Director | Grant | 3K | $0.00 | $0 | 8K |
| 2026-02-06 | Vincent Bernadette N | Director | Grant | 3K | $0.00 | $0 | 4K |
| 2026-02-06 | Towne Bradford K | Principal Accounting Officer | Grant | 8K | $0.00 | $0 | 9K |
| 2026-02-06 | Schlorff Eric | Chief Executive Officer | Grant | 30K | $0.00 | $0 | 40K |
| 2026-02-06 | Neuman John | Director | Grant | 3K | $0.00 | $0 | 12K |
| 2026-02-06 | Chung Kevin | Chief Medical Officer | Grant | 15K | $0.00 | $0 | 21K |
| 2026-02-06 | Baird Jennifer A | Director | Grant | 3K | $0.00 | $0 | 7K |
| 2025-12-19 | Baird Jennifer A | Director | Buy | 4K | $0.24 | $987 | 36K |
| 2025-12-09 | Messinger Michael | Chief Financial Officer | Buy | 15K | $0.35 | $5K | 18K |
| 2025-08-27 | Van Heel Kenneth | Director | Buy | 10K | $0.86 | $9K | 49K |
| 2025-08-26 | Van Heel Kenneth | Director | Buy | 25K | $0.89 | $22K | 39K |
| 2025-08-22 | Chung Kevin | Chief Medical Officer | Buy | 10K | $0.80 | $8K | 58K |
| 2025-07-10 | Vincent Bernadette N | Director | Grant | 4K | $0.00 | $0 | 12K |
| 2025-07-10 | Van Heel Kenneth | Director | Grant | 4K | $0.00 | $0 | 14K |
| 2025-07-10 | Neuman John | Director | Grant | 4K | $0.00 | $0 | 92K |
| 2025-07-10 | Baird Jennifer A | Director | Grant | 4K | $0.00 | $0 | 32K |
| 2025-07-01 | Schlorff Eric | Chief Executive Officer | Exercise or conversion | 22K | $0.00 | $0 | 99K |
| 2025-07-01 | Chung Kevin | Chief Medical Officer | Exercise or conversion | 5K | $0.00 | $0 | 48K |
| 2025-06-30 | Baird Jennifer A | Director | Buy | 10K | $0.42 | $4K | 28K |
| 2025-06-24 | Neuman John | Director | Buy | 40K | $0.36 | $14K | 80K |
| 2025-06-04 | Baird Jennifer A | Director | Exercise or conversion | 3K | $0.00 | $0 | 18K |
| 2025-06-04 | Vincent Bernadette N | Director | Exercise or conversion | 3K | $0.00 | $0 | 8K |
| 2025-06-04 | Van Heel Kenneth | Director | Exercise or conversion | 4K | $0.00 | $0 | 10K |
| 2025-06-04 | Neuman John | Director | Exercise or conversion | 3K | $0.00 | $0 | 88K |
| 2025-05-20 | Chung Kevin | Chief Medical Officer | Buy | 5K | $1.25 | $6K | 18K |
| 2025-05-20 | Baird Jennifer A | Director | Buy | 10K | $1.28 | $13K | 10K |
| 2024-12-11 | Neuman John | Director | Buy | 10K | $2.04 | $20K | 40K |
| 2024-11-18 | Chung Kevin | Chief Medical Officer | Buy | 4K | $1.99 | $8K | 14K |
| 2024-09-30 | Chung Kevin | Chief Medical Officer | Buy | 1K | $4.26 | $4K | 9K |
| 2024-08-30 | Green David A | Chief Financial Officer | Grant | 8K | $0.00 | $0 | 10K |
| 2024-08-15 | Neuman John | Director | Buy | 10K | $5.24 | $52K | 30K |
| 2024-06-17 | Neuman John | Director | Buy | 10K | $4.35 | $44K | 20K |
| 2024-06-14 | Neuman John | Director | Buy | 10K | $3.69 | $37K | 10K |
| 2024-04-18 | Green David A | Chief Financial Officer | Grant | 2K | $0.00 | $0 | 2K |
| 2024-04-12 | Rodgers Bruce M. | Director | Grant | 37K | $0.00 | $0 | 45K |
| 2024-04-12 | Collins Allan | Director | Grant | 38K | $0.00 | $0 | 54K |
| 2024-04-12 | Van Heel Kenneth | Director | Grant | 44K | $0.00 | $0 | 160K |
| 2024-04-12 | Barnett Rick | Director | Grant | 70K | $0.00 | $0 | 87K |
| 2024-04-12 | Lobo Andres | Director | Grant | 32K | $0.00 | $0 | 40K |
| 2024-04-12 | Russell Richard D. | Director | Grant | 32K | $0.00 | $0 | 60K |
| 2024-04-12 | Green David A | Chief Financial Officer | Grant | 753K | $0.00 | $0 | 753K |
| 2023-11-29 | Baron Caryl | Interim CFO | Grant | 20K | $0.00 | $0 | 140K |
| 2023-11-29 | Chung Kevin | Chief Medical Officer | Grant | 63K | $0.00 | $0 | 211K |
| 2023-11-29 | Schlorff Eric | Chief Executive Officer | Grant | 60K | $0.00 | $0 | 838K |
| 2023-11-22 | Van Heel Kenneth | Director | Buy | 100K | $0.40 | $40K | 116K |
| 2023-09-22 | Baron Caryl | Interim CFO | Other transaction | 15K | $0.00 | $0 | 120K |
| 2023-09-15 | Schlorff Eric | Chief Executive Officer | Grant | 41K | $0.00 | $0 | 780K |
| 2023-09-15 | Chung Kevin | Chief Medical Officer | Grant | 34K | $0.00 | $0 | 154K |
| 2023-09-15 | Baron Caryl | Interim CFO | Grant | 4K | $0.00 | $0 | 105K |
| 2023-08-31 | Schlorff Eric | Chief Executive Officer | Grant | 34K | $0.00 | $0 | 736K |
| 2023-08-31 | Chung Kevin | Chief Medical Officer | Grant | 28K | $0.00 | $0 | 113K |
| 2023-08-31 | Baron Caryl | Interim CFO | Grant | 3K | $0.00 | $0 | 100K |
| 2023-08-31 | Schlorff Eric | Chief Executive Officer | Grant | 35K | $0.00 | $0 | 739K |
| 2023-08-31 | Chung Kevin | Chief Medical Officer | Grant | 35K | $0.00 | $0 | 120K |
| 2023-08-15 | Schlorff Eric | Chief Executive Officer | Grant | 20K | $0.00 | $0 | 702K |
| 2023-08-15 | Baron Caryl | Interim CFO | Grant | 2K | $0.00 | $0 | 97K |
| 2023-08-15 | Schlorff Eric | Chief Executive Officer | Grant | 21K | $0.00 | $0 | 704K |
| 2023-08-15 | Chung Kevin | Chief Medical Officer | Grant | 17K | $0.00 | $0 | 85K |
| 2023-06-23 | Schlorff Eric | Chief Executive Officer | Grant | 417K | $0.00 | $0 | 682K |
| 2023-06-09 | Baron Caryl | Interim CFO | Grant | 57K | $0.00 | $0 | 110K |
| 2023-06-09 | Baron Caryl | Interim CFO | Tax withholding | 15K | $0.53 | $8K | 95K |
| 2023-05-30 | Chung Kevin | Chief Medical Officer | Buy | 1K | $0.48 | $552 | 68K |
| 2023-05-30 | Chung Kevin | Chief Medical Officer | Buy | 2K | $0.48 | $1K | 67K |
| 2023-05-30 | Chung Kevin | Chief Medical Officer | Buy | 4K | $0.48 | $2K | 65K |
| 2023-05-30 | Chung Kevin | Chief Medical Officer | Buy | 5K | $0.47 | $2K | 61K |
| 2023-05-25 | Russell Richard D. | Director | Buy | 20K | $0.50 | $10K | 28K |
| 2023-05-18 | Chung Kevin | Chief Medical Officer | Buy | 8K | $0.70 | $5K | 56K |
| 2023-04-06 | Russell Richard D. | Director | Grant | 8K | $0.00 | $0 | 8K |
| 2023-04-06 | Lobo Andres | Director | Grant | 8K | $0.00 | $0 | 8K |
| 2023-04-06 | Barnett Rick | Director | Grant | 8K | $0.00 | $0 | 16K |
| 2023-04-06 | Van Heel Kenneth | Director | Grant | 8K | $0.00 | $0 | 16K |
| 2023-04-06 | Collins Allan | Director | Grant | 8K | $0.00 | $0 | 16K |
| 2023-04-06 | Schlorff Eric | Chief Executive Officer | Grant | 66K | $0.00 | $0 | 265K |
| 2023-04-06 | Baron Caryl | Interim CFO | Grant | 11K | $0.00 | $0 | 53K |
| 2023-04-06 | Rodgers Bruce M. | Director | Grant | 8K | $0.00 | $0 | 8K |
| 2022-10-28 | LMFAO Sponsor, LLC | TenPercentOwner | Exercise or conversion | 2.6M | $0.00 | $0 | 2.6M |
| 2022-10-28 | LM FUNDING AMERICA, INC. | TenPercentOwner | Exercise or conversion | 2.6M | $0.00 | $0 | 2.6M |
| 2022-10-28 | Barnett Rick | Director | Grant | 8K | $0.00 | $0 | 8K |
| 2022-10-28 | Schlorff Eric | Chief Executive Officer | Grant | 199K | $0.00 | $0 | 199K |
| 2022-10-28 | Collins Allan | Director | Grant | 8K | $0.00 | $0 | 8K |
| 2022-10-28 | Van Heel Kenneth | Director | Grant | 8K | $0.00 | $0 | 8K |
| 2022-10-28 | Baron Caryl | Interim CFO | Grant | 42K | $0.00 | $0 | 42K |
| 2022-10-28 | Dow Employees' Pension Plan Trust | TenPercentOwner | Grant | 4.1M | price not stated in the filing | not stated | 4.1M |
| 2022-10-28 | Dow Employees' Pension Plan Trust | TenPercentOwner | Buy | 300K | $10.00 | $3.0M | 4.4M |
| 2022-10-28 | Union Carbide Employees' Pension Plan Trust | TenPercentOwner | Buy | 200K | $10.00 | $2.0M | 3.0M |
| 2022-10-28 | Union Carbide Employees' Pension Plan Trust | TenPercentOwner | Grant | 2.8M | price not stated in the filing | not stated | 2.8M |
| 2022-04-06 | Chung Kevin | Chief Medical Officer | Grant | 44K | $0.00 | $0 | 48K |
| 2022-04-05 | Chung Kevin | Chief Medical Officer | Buy | 4K | $1.85 | $7K | 4K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON6 holders report 5% or more of ICU in their latest filing, all on Schedule 13G (passive). The largest reported stake is Intracoastal Capital LLC at 10.0% of the class (443,253 shares), filed 2026-05-13 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-13 | 13G/Ano. 3 | Intracoastal Capital LLCother entity | 443K | 10.0% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 3 | Daniel B. Asherparent holding company, individual | 443K | 10.0% | 2026-03-31 |
| 2026-05-13 | 13G/Ano. 3 | Mitchell P. Kopinparent holding company, individual | 443K | 10.0% | 2026-03-31 |
| 2026-05-11 | 13G | Waqas Khatriindividual | 278K | 6.5% | 2026-03-31 |
| 2026-05-11 | 13G | Alto Opportunity Master Fund, SPC - Segregated Master Portfolio Bcorporation | 278K | 6.5% | 2026-03-31 |
| 2026-05-11 | 13G | Ayrton Capital LLCinvestment adviser | 278K | 6.5% | 2026-03-31 |
What this page is
SeaStar Medical Holding in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows SeaStar Medical Holding (ICU), SEC CIK 1831868, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-03.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-13.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-18.JSON and CSV
- Company record
- EDGAR filing index for CIK 1831868Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
Datasets
Frequently Asked Questions
How much of ICU is sold short?
185,839 shares were held short at the 2026-10-15 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is ICU's daily short volume?
On 2026-11-03, 289,795 of the 508,768 ICU shares reported to FINRA were sold short, 57.0% of the day's reported volume. Short volume is a flow for one day, not a position.
Does ICU have fails to deliver?
The SEC's latest file shows 44,694 ICU shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are ICU insiders buying or selling?
Insiders at ICU reported 1 open-market buy worth $2K in the last 90 days and no open-market sells. Latest filing: Messinger Michael (Chief Financial Officer) on 2026-08-18.
Who owns 5% or more of ICU?
6 holders report 5% or more of ICU in their latest filing, all on Schedule 13G (passive). The largest reported stake is Intracoastal Capital LLC at 10.0% of the class (443,253 shares), filed 2026-05-13 for an event on 2026-03-31.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.